South Boston or Boston or San Francisco or Zug or London
$70-$80/hrHybridFull Time, Contract
CRISPR TherapeuticsNASDAQ: CRSP: Develops gene-editing medicines using the CRISPR/Cas9 platform.
3+ YOEBachelor’s degree in statistics, mathematics, or computer science/IT; 3+ years of statistical programming in pharmaceutical, biotech, or CRO settings; strong SAS and CDISC expertise.
SAS, CDISC, SDTM, ADaM, SAS/BASE, SAS/STAT, SAS/GRAPH, SAS Macro, 21 CFR Part 11
Revolution MedicinesNASDAQ: RVMD: Developing precision oncology therapies for RAS-addicted cancers
14+ YOE14+ years of Statistical Programming experience in exploratory-stage oncology trials; BS/BA; leadership of contractors; SAS programming experience.
Gilead SciencesNASDAQ: GILD: Develops and sells medicines for life-threatening infectious diseases.
8+ YOEAdvanced statistical programming experience for clinical trials, regulatory submissions, SAS and CDISC expertise, leadership and project management in pharma/CRO.
SAS, SAS Macros, Microsoft Excel, CDISC, ADaM, SDTM, CDASH
Gilead SciencesNASDAQ: GILD: Develops and sells medicines for life-threatening infectious diseases.
9+ YOEPhD in biostatistics or related field, 9+ years industry or academic clinical trial experience, expert statistical methods, proficiency in R or SAS, strong communication and leadership.
Senior Manager, Statistical Programming - Oncology Early Development
South San Francisco, California, United States
$125k-$237k/yrHybridFull Time
AbbVieNYSE: ABBV: Develops and sells innovative pharmaceutical and biopharmaceutical medicines.
9+ YOE2+ MgmtMS (9+ yrs) or BS (11+ yrs) in Statistics/Computer Science or related, 2+ yrs leading statistical programming teams, deep SAS and CDISC knowledge, drug development and regulatory filing experience.
Summit TherapeuticsNASDAQ: SMMT: Developing oncology therapies to improve patient quality of life.
7+ YOEBachelor’s or Master’s degree in biostatistics, statistics, computer science or related field; 7+ years of pharmaceutical/biotech programming experience; SAS, CDISC, regulatory, and clinical trial expertise.
ADaM, Base SAS, SAS macros, SAS/STAT, SAS/Graph, SAS/SQL, SAS/OD, CDISC, SDTM, MedDRA, WHODD, Pinnacle 21, R, Python
AbbottNYSE: ABT: Manufactures medical devices, diagnostics, and nutritional health products.
1+ YOEAssociate degree and 1+ year of experience required. SAS skills, statistical knowledge, clinical research experience, communication, organization, attention to detail, and deadline management required.
AbbottNYSE: ABT: Provides medical devices, diagnostics, and science-based nutritional products.
1+ YOEAssociate's degree and at least one year of experience required. Requires statistical knowledge, SAS skills, clinical research support, communication, organization, attention to detail, and deadline management.
PenumbraNYSE: PEN: Designs and manufactures medical devices for vascular conditions.
8+ YOEBachelor's degree plus 8+ years experience in statistical programming for clinical research; strong leadership, regulatory filing and clinical trial knowledge; expertise in SAS macro development and programming standards.
RocheSIX Swiss Exchange: ROG: Develops and manufactures innovative medicines and diagnostic tests.
Master's in statistics/biostatistics/computer science, professional experience in statistical modeling, programming in SAS and/or R/R Shiny, knowledge of FDA and ICH guidelines, and clinical research experience.
CareDxNASDAQ: CDNA: Develops diagnostic tests and digital tools for transplant care.
5+ YOEPhD in statistics or related field,5+ years industry experience in pharma/biotech,expertise in R and SAS,statistical design and analysis skills,experience mentoring and contributing to regulatory submissions.
10+ YOE10+ years clinical trial statistical programming experience, deep SAS and CDISC SDTM/ADaM knowledge, Pinnacle 21 experience, submission readiness, MS preferred, strong communication and independent problem-solving skills.
SAS BASE, SAS MACRO, SAS STAT, SAS GRAPH, SAS ACCESS, CDISC SDTM, CDISC ADaM, Pinnacle 21, Spotfire, Tableau, RShiny
Annexon BiosciencesNASDAQ: ANNX: Develops therapies for complement-mediated neuroinflammatory and autoimmune diseases.
8+ YOE8+ MgmtMS with 8+ years or BS with 10+ years in statistical programming leadership in pharma/biotech; deep CDISC knowledge, FDA/EMA submission experience, SAS expertise, and understanding of GCP/ICH/21 CFR Part 11.
University of California, San Francisco: Public research university dedicated to health sciences and education.
3+ YOEMaster’s degree in public health, epidemiology, statistics, or related field; 3+ years managing complex research datasets; REDCap and clinical trial experience; pregnancy data analysis; SAS or similar statistical software.
Stanford University: A private research university providing higher education and research.
3+ YOEMaster’s degree in biostatistics, statistics, or a related field plus 3 years of experience. Proficiency in at least two of R, SAS, SPSS, or STATA is required.
Aditum Bio: Biotech venture firm incubating and developing clinical-stage therapies.
12+ YOE5+ MgmtPhD/MS in biostatistics/statistics,12+ years biometrics experience with 5+ years leading statistical strategy for Phase I/II; hands-on R/SAS programming, CDISC/EDC knowledge, dashboarding and regulatory interaction experience.
R, SAS, Spotfire, Tableau, Power BI, R Shiny, EDC, CDISC
Allogene TherapeuticsNASDAQ: ALLO: Develops allogeneic cell therapies for cancer and autoimmune diseases
6+ YOEBS/MS in Statistics/Data Science or related (BS required, MS preferred), 6+ years biotech/pharma experience, expertise in applied statistics, hands‑on with R, Python, JMP, SAS, GMP knowledge, and U.S. work authorization.
Bristol Myers SquibbNew York Stock Exchange: BMY: Develops and distributes innovative medicines for serious diseases.
3+ YOEPhD+3yrs or MS+5yrs in statistics/biostatistics, proficiency in SAS,R,Python, experience with clinical trials, regulatory knowledge, strong communication and leadership skills.